Ischemia-induced coronary collateral growth is dependent on vascular endothelial growth factor and nitric oxide

Circulation

Volumn 102, Issue 25, 2000, Pages 3098-3103

  Matsunaga, Toshiro ^a   Warltier, David C ^a   Weihrauch, Dorothee W ^a   Moniz, Melinda ^a   Tessmer, John ^a   Chilian, William M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Collateral circulation; Endothelium derived factors; Hyperemia; Nitric oxide

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRIC OXIDE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY COLLATERAL CIRCULATION; DOG; FEMALE; HEART MUSCLE ISCHEMIA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0034687598     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.102.25.3098     Document Type: Article

References (35)

1. Pathways and functional significance of the coronary collateral circulation
2. The coronary collateral circulation: Determinants and functional significance in ischemic heart disease
3. Functional importance of coronary collateral vessels
4. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction
5. Molecular mechanism of coronary collateral vessel growth
6. Collateral circulation and diabetes
7. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells
8. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
9. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia
10. Temporal dependence of coronary collateral development
11. Repetitive coronary artery occlusions induce release of growth factors into the myocardial interstitium
12. Activation-induced expression of vascular permeability factor by human peripheral T cells: A non-radioisotopic semiquantitative reverse transcription-polymerase chain reaction assay
13. Evaluation of coronary collateral development regional myocardial function and reactive hyperemia
14. Development of collateral function with repetitive coronary occlusion in a canine model reduces myocardial reactive hyperemia in the absence of significant coronary stenosis
15. Vascular endothelial growth factor (VEGF) and its receptors
16. The role of growth factors during development of a collateral circulation in the porcine heart
17. Upregulation of vascular endothelial growth factor expression induced by myocardial ischemia: Implication for coronary angiogenesis
18. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
19. 165 solo therapy for myocardial ischemia
20. VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis
21. Role of nitric oxide in reactive hyperemia of the guinea pig heart
22. Role of endothelium-derived nitric oxide in myocardial reactive hyperemia
23. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
24. Superoxide anion production is increased in a model of genetic hypertension: Role of the endothelium
25. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition
26. Blunted cardiovascular growth induction during prolonged nitric oxide synthase blockade
27. Effects of factors predisposing to atherosclerosis on formation of coronary collateral vessels
28. Coronary collateral circulation in coronary artery disease and systemic hypertension
29. Regulation of native collateral vessel dilation after coronary occlusion in the dog
30. Development of endothelium-dependent relaxation in canine coronary collateral arteries
31. Nitric oxide: Physiology, pathophysiology, and pharmacology
32. The vascular biology of nitric oxide and its role in atherogenesis
33. Effect of diabetes mellitus on formation of coronary collateral vessels
34. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus
35. Effects of coronary artery disease on expression and microvascular response to VEGF